baber/WOPTO huggingface dataset:
Patent AU-2001291667-B2 (AU)
Title: A method for electrolytic galvanising using electrolytes containing alkane sulphonic acid
Inventor: JAGER HANS-ULRICH
IPC: C25D3/22
Filed: 2001-07-09
Granted: 2005-07-14
Abstract: The invention relates to a process for the electrolytic coating of metals with zinc or a zinc alloy in which matt surfaces are obtained, by deposition of zinc from an electrolyte solution comprising a zinc salt selected from zinc sulfate or an alkanesulfonate of zinc or mixtures thereof, and, if desired, further metal salts, an acid selected from sulfuric acid or an alkanesulfonic acid or a mixture of the two acids, and at least one additive for improving the surface roughness and preventing dendritic edge growth, selected from nitrogen-containing surface-active compounds, which may be ionic or nonionic, sulfur-containing anionic surface-active compounds, and surface-active compounds based on multifunctional alcohols having at least three hydroxyl groups. The invention furthermore relates to an electrolyte composition for electrolytic coating of metals with zinc or zinc alloys, and to the use of said additives for improving the surface roughness and preventing dendritic edge growth in the electrolytic coating of metals with zinc or a zinc alloy in an alkanesulfonic acid-containing electrolyte.
Patent AU-2001297778-B2 (AU)
Title: NSAID formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
Inventor: LICHTENBERGER LENARD
IPC: A61P1/04
Filed: 2001-12-19
Granted: 2007-05-31
Abstract: A novel pharmaceutical composition is provided by which nonsteroidal anti-inflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such as lecithin oils or to a bio-compatible oil to which an phospholipid has been added to make a NSAID-containing formulation that possess low gastrointestinal (GI) toxicity and enhanced therapeutic activity to treat or prevent inflammation, pain, fever, platelet aggregation, tissue ulcerations and/or other tissue disorders. The composition of the invention are in the form of a non-aqueous solution, paste, suspension, dispersion, colloidal suspension or in the form of an aqueous emulsion or microemulstion for internal, oral, direct or topical administration.
Patent AU-2002315575-B2 (AU)
Title: Stopper rod
Inventor: HANSE ERIC
IPC: B22D11/10
Filed: 2002-06-06
Granted: 2006-09-07
Abstract: There is provided a refractory mono-block stopper of substantially cylindrical configuration having an upper end, a lower end and an axial bore extending downwardly from the upper end, means being provided in the axial bore at a distance d from the upper end for attachment of the stopper to a lifting mechanism, the stopper being divided into three portions (A,B,C); a first portion (A) extending from the upper end towards the lower end until a distance greater than d, a second portion (B) extending from the first portion (A) towards the lower end and a third portion (C) extending from the second portion (B) and comprising a stopper nose ending at the lower end of the stopper. The stopper of the invention is characterized in that the average section of the second portion (B) is lower than the section of the first portion (A) and the highest section of the third portion (C) is higher than the lowest section of the second portion (B). The stopper of the invention has a significantly reduced weight without any observable loss of strength. It is also noted that since the profile of the stopper can be kept symmetrical around its axis, the stopper does not require extra handwork to be removed from the mold.
Patent AU-2002318630-B2 (AU)
Title: Antacid and laxative tablets
Inventor: SOFUE HISAE
IPC: A61K9/20
Filed: 2002-07-08
Granted: 2007-05-17
Abstract: An antacid and laxative tablet comprising magnesium oxide particles as an effective component, wherein  (i) the magnesium oxide particles contained in the tablet have an average secondary particle diameter measured by a laser diffraction scattering method of 0.5 to 10  mu m, (ii) the content of magnesium oxide particles in the tablet is 88 wt% or more, (iii) the tablet does not become blackish and has substantially no tableting spot, and (iv) the disintegration time is 10 sec or less.  <??>The antacid and laxative tablet of the present invention has a high content of magnesium oxide particles, a short disintegration time, does not become blackish, has no tablet trouble and no tableting spot and is suitably administered orally.
Patent AU-2003224729-B2 (AU)
Title: (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
Inventor: GE CHUANSHENG
IPC: A61P19/02
Filed: 2003-03-20
Granted: 2008-01-03
Abstract: Discussed is stereomerically pure (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, or a pharmaceutically acceptable polymorph, salt, solvate or hydrate thereof, as well as a pharmaceutical composition or single unit dosage form comprising such compound and such compound for use as a medicine.
Patent AU-2003236364-B2 (AU)
Title: Medicinal compositions improving brain function and method for improving brain function
Inventor: NAKAGAWA MASAYA
IPC: A61K31/21
Filed: 2003-04-03
Granted: 2008-08-21
Abstract: Use of a following ingredients in combination for use in the treatment or prevention of dysfunction of cerebral acetylcholine neurons in the sequela of cerebrovascular dementia, senile dementia, Alzheimer's disease, ischemic cerebral lesion and cerebral apoplexy or the memory impairment caused by selective neuronal death: 
Ingredient (A): 
an alkyl ether derivative represented by the following formula:   
wherein either 
(R 1  represents a benzothienyl group; 
R 2  represents a hydrogen atom; 
R 3  and R 4 , each represents a C 1-6 alkyl group which is optionally substituted with a hydroxyl group; 
R 3  and R 4 , taken conjointly with the nitrogen atom to which R 3  and R 4  are linked, form an azetidine ring which is optionally substituted with a hydroxyl group; 
m represents an integer of 1; and 
n represents an integer of 3); 
or a salt thereof,  
Ingredient (B) : 
Tacrine or 
Donepezil 
for the manufacture of a pharmaceutical composition.
Patent AU-2003276416-B2 (AU)
Title: Preconditioning of a substrate in a continuous process for manufacture of electrochemical sensors
Inventor: DAVIES OLIVER WILLIAM HARDWICKE
IPC: H05K1/02
Filed: 2003-10-30
Granted: 2009-07-16
Abstract: The present invention described a method of preconditioning a substrate in a web manufacturing process wherein the web manufacturing process includes a plurality of printing steps, the method comprising the steps of moving the substrate through the web manufacturing process under tension; heating the substrate as the substrate is passed through the printing steps, wherein the substrate temperature does not exceed a first predetermined temperature during the printing steps; and passing the substrate into a preconditioning station wherein the substrate is heated to a second temperature which exceeds the first temperature.
Patent AU-2004202394-B2 (AU)
Title: Electrically Conductive Confined Space Ventilator Conduit Formed of Conductive Polymer, Electrical Grounding Circuit for Ventilation System Using Same, and Methods of Using and Forming Same
Inventor: ANGELICO DAVID FRANK
IPC: B65D90/34
Filed: 2004-05-31
Granted: 2007-11-22
Abstract: An electrically conductive confined space ventilator conduit comprises a central section (20) and at least two outer cylindrical sections (22). The central section has a non-cylindrical shape to minimize obstruction to person entering/leaving a port in an enclosure e.g. tanks or sewers that causes reduction in air flow rate of only = 10% relative to the flow rate in a second conduit having a diameter equal to that of the outer section. Independent claims are included for the following: (1) electrically grounding an electrically conductive confined space ventilation conduit; and (2) a kit comprising at least one electrically conductive connector and an electrically conductive confined space ventilator conduit.
Patent AU-2004210203-B2 (AU)
Title: Tanning booth
Inventor: STAFFORD-NELSON CHRISTOPHER
IPC: B05B13/04
Filed: 2004-02-06
Granted: 2009-05-14
Abstract: A booth ( 2 ) for accommodating a person, the booth ( 2 ) defining a booth volume ( 4 ) and comprising: a base portion ( 6 ) and a top portion ( 8 ); flow means for causing air to move in a downward air flow within the booth ( 2 ), the downward airflow defining a predetermined volume within the booth ( 2 ); recirculating means ( 18 ) for recirculating the air within the booth ( 2 ); iltering means ( 20 ) for filtering the air within the booth ( 2 ); and projecting means for projecting a product into at least some of the booth volume and onto a body of a person positioned in the booth ( 2 ).
Patent AU-2004213190-B2 (AU)
Title: Control valve in a percussion device and a method comprising a closed pressure space at the end position of the piston
Inventor: KOSKIMAKI ANTTI
IPC: B25D9/20
Filed: 2004-02-23
Granted: 2008-11-06
Abstract: The invention relates to a control valve, a percussion device and a method of controlling a working cycle of a percussion device. A percussion device ( 1 ) for breaking rock includes an impact element ( 8 ) controlled by a control valve ( 2 ). The control valve includes a control element ( 5 ) arranged to control channels ( 7 b) leading to a working pressure surface ( 9 ) of the impact element ( 8 ). The control element, during a working cycle of the control valve, is arranged to open and close pressure channels at several connecting moments so that during one working cycle of the valve, several impact pulses are arranged to be produced.
Patent AU-2004218879-B2 (AU)
Title: Methods of radiofluorination of biologically active vectors
Inventor: CUTHBERTSON ALAN
IPC: C07C243/14
Filed: 2004-03-12
Granted: 2009-10-01
Abstract: The invention relates to conjugates of formula (V) or (VI): wherein X is —CO—NH—, —NH—, —O—, —NHCONH—, or —NHCSNH—; their use as radiopharmaceuticals, processes for their preparation, and synthetic intermediates used in such processes.
Patent AU-2004274488-B2 (AU)
Title: Interpolymers suitable for use in hot melt adhesives and processes to prepare same
Inventor: KARJALA TERESA
IPC: C09J123/08
Filed: 2004-09-17
Granted: 2010-09-09
Abstract: An ethylene interpolymer having the following properties:P 
i) a density from 0.88 to 0.93 g/cm 3 ; 
ii) a number average molecular weight (Mn) from 1,000 to 9,000 and  
wherein the interpolymer comprises a high weight average molecular weight polymer component (M wH ) and a low weight average molecular weight polymer component (M wL ), and wherein the ratio(M Wh /M wL ) is from 1.5 to 20.
Patent AU-2005202389-B2 (AU)
Title: Novel adhesive composition
Inventor: WILFRID LANGEZAAL
IPC: C08G18/10
Filed: 2005-05-27
Granted: 2011-07-07
Abstract: 5 The invention provides an adhesive or sealant composition comprising a cross-linkable polymer, a cross-linking catalyst for the polymer, a rheology controller, a water scavenger, wherein said cross-linkable polymer is silyl-end capped and has an equivalent molecular weight between 10 10,000 and 20,000. The invention also provides uncured and cured adhesive compositions, processes for direct glazing of a windscreen on a metallic automotive frame; process for manufacturing the compositions of the invention and uses of the 15 compositions of the invention.
Patent AU-2005237976-B2 (AU)
Title: Rivet collating system including rivet holder and method of forming the same
Inventor: MUSIL EDWARD C
IPC: B25C3/00
Filed: 2005-04-11
Granted: 2012-03-01
Abstract: A rivet collating system is provided that includes a rivet holder for supporting rivets in a predetermined pattern. In one form, the rivet holder includes a unitary plate in which apertures are configured for supporting the rivets depending therefrom. In another form, the collating system includes a plate body and drive heads that are integrally connected via frangible portions to the plate body. Preferably, retaining webs are provided about the apertures to releasably hold the rivet heads therein. The drive heads are driven downward to sever the frangible portions with the webs flexing to release the rivet heads so that the rivets can be received in bores of a guide block of a belt fastener installation tool. A method of manufacture of the rivet holders is also disclosed.
Patent AU-2005274510-B2 (AU)
Title: Individualized security document
Inventor: HANSEN ACHIM
IPC: B42D15/10
Filed: 2005-05-09
Granted: 2010-02-25
Abstract: The invention concerns an individualized security document (1) and a method of individualizing a security document. The individualized security document (1) has a number of pages (12 to 15) which are connected together by means of stitching or adhesive. In addition integrated into the security document by means of stitching and adhesive is a single-layer or multi-layer film body (2) which is provided with an individualized optical security element and which is folded in the region of the stitching or adhesive. The fold divides the film body (2) into a first part (21) on which the individualized optical security element is arranged and a second, preferably flap-shaped part (22) which is permanently connected to a plastic body having at least one machine-readable security element, wherein the at least one machine-readable security element has an electronic circuit for RF identification.
Patent AU-2005303576-B2 (AU)
Title: Rotary valve
Inventor: HAMPSON DAVID MARK
IPC: F16K11/074
Filed: 2005-11-08
Granted: 2011-02-10
Abstract: A rotary valve for controlling air supply in an inflatable device comprises a first rotor (11) and the second rotor (12) driven by motor (13) with a drive pulley (14) fixed directly onto its drive spindle (15). A toothed belt (16) driven by the drive pulley (14) engages with the toothed perimeter profile of the first rotor (11), to rotate rotors (11) and (12) relative to a stator (10). As the first and/or second rotor(s) are rotated, channels and ports on the airtight interfaces between the rotors (11, 12) and the stator (10) are connected and disconnected as required by the desired inflation sequence, including all the ports sealed in one position or all the ports exhausting to atmosphere in another position. The valve can be used in conjunction with any type of inflating device, where complex porting or air routing is required, the valve achieving this in a simpler manner.
Patent AU-2005321287-B2 (AU)
Title: Method and device for content information sharing
Inventor: ZHOU YU CHEN
IPC: H04L29/08
Filed: 2005-12-22
Granted: 2011-09-08
Abstract: A method and device for content information sharing is provided. The method comprises a first device receiving a content information request from at least a second device via a network, said content information request comprises the capability information of the second device; said first device retrieving the information of the content that the first device could provide; said first device filtering the content information of the content that the first device could provide according to the capability information of the second device; and said first device sending the filtered content information of the content that the first device could provide to the second device. According to the present invention, every device could select to obtain the content information or the content that the device could process or display.
Patent AU-2005331246-B2 (AU)
Title: Isolation and purification of carotenoids from Marigold flowers
Inventor: MADAVALAPPIL KUNHIRAMAN PRIYA
IPC: C07C403/00
Filed: 2005-04-25
Granted: 2011-04-21
Abstract: The present invention explains a realistic and effective process for isolating and purifying carotenoids containing higher concentrations of carotenoids such as trans-lutein, trans-zeaxanthin, Cis-lutein, beta-carotene and Cryptoxanthin from Marigold flower petals under controlled conditions leaving no traces of any organic hazardous solvents. The process involves ensilaging Marigold flowers, dehydration, solvent extraction, alkali hydrolysis of carotenoid esters with absolute alcohol, crystallization/purification using water, absolute alcohol mixture followed by filteration and drying until the crystals are considerably free from moisture and absolutely free from residual hazardous solvents. These crystals are suitable for nutraceutical and food products as supplements.
Patent AU-2006201431-B2 (AU)
Title: Lock mounting system
Inventor: BUSCH CRAIG
IPC: B65D55/02
Filed: 2006-04-05
Granted: 2012-11-01
Abstract: LOCK MOUNTING SYSTEM A lock mounting structure for mounting a lock (60) to a part (30) of a container 5 (10) is disclosed. The lock mounting structure comprises an outer part adapted to form an outer portion of the container part (30) and an inner part adapted to form an inside portion of the container part (30) and having a first surface (50) for facing towards the inside of the container (10). The inner part includes a mounting structure (Figs 4 and 5) for mounting the lock (60) thereto. The mounting structure (Figs 4 and 5) extends outwardly 1o from the first surface (50). The structure also includes an aperture (36) for accessing a key receiving end (62) of the lock (60). The lock mounting structure (Figs 4 and 5) is formed as an integral piece. 434 3 5 0 3 45 2 38-.. 43 45 -4 o 11 0 i 42
Patent AU-2006204521-B2 (AU)
Title: Transplastomic plants free of the selectable marker gene
Inventor: FERULLO JEAN-MARC
IPC: C12N15/82
Filed: 2006-01-03
Granted: 2010-06-10
Abstract: Obtaining a transplastomic plant free of selectable marker comprises transforming at least one plant cell with a vector for the transformation of plastids. Obtaining a transplastomic plant free of selectable marker comprises: (a) transforming at least one plant cell with a vector for the transformation of plastids, comprising, in the direction of transcription, a sequence (i) corresponding to the 5' portion of a chimeric gene of interest, a chimeric gene (ii) comprising a sequence encoding a selectable marker that confers resistance to a selection agent, a fragment (iii) of n nucleotides that is identical to the 3' portion of the sequence (i), and a sequence (iv) corresponding to the remaining 3' portion of the chimeric gene of interest; (b) culturing the cells comprising the transformed plastids on a first medium comprising the selection agent; and (c) culturing the cells on a second medium that does not comprise the selection agent. Independent claims are also included for: (1) a construct comprising, in the direction of transcription, a sequence (i) corresponding to the 5' portion of a chimeric gene of interest, a chimeric gene (ii) comprising a sequence encoding a selectable marker, a fragment (iii) of n nucleotides that is identical to the 3' portion of the sequence (i), and a sequence (iv) corresponding to the remaining 3' portion of the chimeric gene of interest; (2) a transformation vector, for the transformation of plant plastids, comprising the construct; (3) a transplastomic plant cell containing a gene of interest and free of selectable marker, that can be obtained by means of the new method; and (4) a transplastomic plant or a part of this plant, and the progeny of this plant, containing a gene of interest and free of selectable marker, that can be obtained by means of the new method. ACTIVITY : Plant Protectant. MECHANISM OF ACTION : None given.
Patent AU-2006211049-B2 (AU)
Title: Purification of streptococcal capsular polysaccharide
Inventor: COSTANTINO PAOLO
IPC: C08B37/00
Filed: 2006-02-01
Granted: 2012-06-07
Abstract: A purification process for the capsular polysaccharide of S.agalactiae in which the saccharide is initially treated with an aqueous mixture of an alcohol and a calcium salt, followed by precipitation with a cationic detergent. The process can be completed in less than three days and has a yield of around 60%. It avoids the need for DNase, RNase and/or protease treatment. The saccharides of the process have a very low protein contamination and a very low absorbance at 280nm.
Patent AU-2006220133-B2 (AU)
Title: Evaluation of sympathetic tone
Inventor: MAGNUSSON GISLI
IPC: A61B5/24
Filed: 2006-03-02
Granted: 2012-09-06
Abstract: The invention relates to a method of determining the sympathetic tone Including the steps of: measuring an applied stimulation at a threshold value of the stimulation in one or more sympathetic tone-neutral points and measuring an applied stimulation at the same threshold value in one or more sympathetic tone-dependent points. The invention further relates to a system for applying and measuring a stimulation, and the use of a system for applying and measuring a stimulation for determining the sympathetic tone including the steps of: measuring an applied stimulation at a threshold value of the stimulation at one or more sympathetic tone-neutral points and measuring an applied stimulation at the same threshold value of the stimulation at one or more sympathetic tone-dependent points.
Patent AU-2006221859-B2 (AU)
Title: Lipocalin protein
Inventor: MELANIE YORKE-SMITH
IPC: C07K14/47
Filed: 2006-03-08
Granted: 2011-09-22
Abstract: The invention is based on the discovery that the human protein referred to herein as INSP181 protein is a lipocalin.
Patent AU-2006272776-B2 (AU)
Title: Methods for rapid identification and quantitation of nucleic acid variants
Inventor: LOWERY KRISTIN SANNES
IPC: C12Q1/68
Filed: 2006-07-21
Granted: 2012-01-19
Abstract: There is a need for nucleic acid analysis which is both specific and rapid, and in which no nucleic acid sequencing is required. The present invention addresses this need, among others by providing a method of nucleic acid amplification of overlapping sub- segments of a nucleic acid followed by molecular mass measurement of resulting amplification products by mass spectrometry, and determination of the base compositions of the amplification products.
Patent AU-2006284808-B2 (AU)
Title: Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
Inventor: DESAI NEIL P
IPC: A61K31/337
Filed: 2006-08-30
Granted: 2012-08-16
Abstract: The present invention provides compositions comprising a poorly water soluble pharmaceutical agent, a carrier protein, and an antimicrobial agent, wherein significant microbial growth is inhibited in the composition. The amount of the antimicrobial agent in the composition may be below the level that induces a toxicological effect or at a level where a potential side effect can be controlled or tolerated. Also provided are compositions comprising a poorly water soluble pharmaceutical agent, a carrier protein, a sugar, and optionally an antimicrobial agent. Methods of using the compositions are also provided.
Patent AU-2006293539-B2 (AU)
Title: Aromatic fibrous strip for consumer pack
Inventor: PHAM XUAN
IPC: B65D85/10
Filed: 2006-07-27
Granted: 2011-03-17
Abstract: A consumer pack with flexible outerwrap around the pack has a tear tape between the pack and the outerwrap for separating the outerwrap into upper and lower portions when the consumer pack is opened. A multi-layer aromatic strip is positioned on an outer surface of the outerwrap just outside the tear tape, and the aromatic strip is secured thereto by an adhesive layer. The aromatic strip includes a fibrous substrate soaked with fragrance and an outer barrier surface that seals in the fragrance. When the tear tape separates the outerwrap into upper and lower portions, the outer barrier surface and the fibrous substrate are broken open to release fragrance to the surroundings.